Results 91 to 100 of about 34,846 (144)

Targeting ADAR1 p150 triggers tumor inhibition and antitumor immunity to overcome immunotherapy resistance. [PDF]

iScience
Ai ZE, Bian Y, Li G, Wang XS, Zhu S, Li Y, Yao X, Yan Z.   +7 more
europepmc   +1 more source

AN IMPROVED F10 SWITCHYARD DESIGN [PDF]

, 1977
openaire   +1 more source

Comparative efficacy and safety of dual-combination vs. triple-combination antihypertensive therapies in hypertensive patients: an updated meta-analysis of randomized controlled trials. [PDF]

Front Pharmacol
Gong Z, Huang L, Long X, Zhang Y.
europepmc   +1 more source

Development of bicistronic plasmids and fusion proteins for clinical translation of tumor immune reprogramming. [PDF]

Mol Ther Adv
Yang J, Chen SS, Idnani E, Shannon SR, Luly K, Fabilane CS, Wilson DS, Spangler JB, Tzeng SY, Green JJ.   +9 more
europepmc   +1 more source

A purpurin-based metalloimmunostimulant amplifies ROS and modulates STING/TNF-α axis to potentiate melanoma immunotherapy. [PDF]

Mater Today Bio
Yang X, Huang M, Pang T, Zhong D, Liu H, Chen X, Liu J, Wen Y.   +7 more
europepmc   +1 more source

Tomato Spotted Wilt Virus Reprogrammes Host Glycolysis to Facilitate Proliferation by a Phase-Separated Co-Aggregate of Nucleocapsid Protein and Phosphoglycerate Kinase. [PDF]

Plant Biotechnol J
Zu G, Xing Z, Li J, Yang T, Wu H, Ge Q, Wang Y, Song B, Song R.   +8 more
europepmc   +1 more source

Fisetin alleviates pulmonary arterial hypertension by inhibiting the TGF-β1/Smad 2/3 signaling pathway. [PDF]

Saudi Pharm J
Xu Y, Kang S, Gong X, Yuan Y.
europepmc   +1 more source

Stimuli-Responsive Silsesquioxane Nanozymes for Organocatalysis in Water and Prodrug Activation in Cells. [PDF]

Angew Chem Int Ed Engl
Zahid R, Lázaro A, Moreno-Alcántar G, Sancho-Albero M, Picchetti P.   +4 more
europepmc   +1 more source

Kasra (Syrie) – F10

, 2015
openaire   +1 more source